CELZ Logo

Creative Medical Technology Holdings, Inc. (CELZ) 

NASDAQ
Market Cap
$3.69M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
596 of 958
Rank in Industry
326 of 549

Largest Insider Buys in Sector

CELZ Stock Price History Chart

CELZ Stock Performance

About Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Insider Activity of Creative Medical Technology Holdings, Inc.

Over the last 12 months, insiders at Creative Medical Technology Holdings, Inc. have bought $0 and sold $0 worth of Creative Medical Technology Holdings, Inc. stock.

On average, over the past 5 years, insiders at Creative Medical Technology Holdings, Inc. have bought $37,105 and sold $132,405 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 200 shares for transaction amount of $872 was made by Warbington Timothy (President & CEO) on 2023‑06‑28.

List of Insider Buy and Sell Transactions, Creative Medical Technology Holdings, Inc.

2023-06-28PurchasePresident & CEO
200
0.0014%
$4.36$872+4.08%
2023-06-27PurchasePresident & CEO
800
0.0057%
$4.44$3,551+2.80%
2022-11-22PurchasePresident & CEO
10,000
0.0712%
$0.39$3,897+28.15%
2022-11-21PurchasePresident & CEO
15,000
0.1096%
$0.40$5,965+28.81%
2022-09-27PurchasePresident & CEO
20,000
0.1403%
$0.50$10,000-1.69%
2022-09-27Purchasedirector
2,000
0.014%
$0.50$1,000-1.69%
2022-09-22PurchasePresident & CEO
12,000
0.0839%
$0.54$6,480-9.49%
2022-09-21PurchasePresident & CEO
30,000
0.2172%
$0.61$18,337-17.21%
2022-06-14Purchase
10,000
0.111%
$0.70$7,000-18.57%
2022-06-06PurchasePresident & CEO
8,000
0.0884%
$0.92$7,358-37.24%
2022-05-20Purchase
6,500
0.1061%
$1.50$9,750-41.17%
2021-07-22Saledirector
1.45M
0.1167%
$0.03$43,645-84.06%
2021-07-21Saledirector
1.5M
0.1196%
$0.03$46,200-84.50%
2021-07-20Saledirector
1.4M
0.1123%
$0.03$42,560-84.14%
2017-08-29SaleCEO & President
5,000
0.0047%
$0.20$1,000-91.70%
2017-08-29Sale10 percent owner
5,000
0.0047%
$0.20$1,000-91.70%
2017-06-05SalePresident & CEO
5,300
0.0051%
$0.30$1,615-96.88%
2017-06-05Sale10 percent owner
5,300
0.0051%
$0.30$1,615-96.88%
2017-06-02SalePresident & CEO
5,700
0.0052%
$0.41$2,324-97.83%
2017-06-02Sale10 percent owner
5,700
0.0052%
$0.41$2,324-97.83%

Insider Historical Profitability

<0.0001%
CREATIVE MEDICAL HEALTH INC.10 percent owner
58655927
3355.9289%
$2.1116
Herbst Timothy10 percent owner
11346667
649.186%
$2.1110
Finger Michael H.director
18502
1.0586%
$2.1130<0.0001%
Warbington TimothyPresident & CEO
12209
0.6985%
$2.1196<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.